Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)

SHA:600671 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,376	1,069	1,420	1,158	1,094	1,049
Market Cap Growth	78.17%	-24.70%	22.61%	5.90%	4.30%	-30.11%
Enterprise Value	2,565	1,174	1,451	1,262	1,178	1,191
Last Close Price	19.51	8.78	11.66	9.51	8.98	8.61
PE Ratio	71.57	70.13	-	-	-	-
PS Ratio	9.44	4.92	11.66	10.63	7.44	5.07
PB Ratio	25.20	12.58	25.38	254.02	16.94	11.23
P/TBV Ratio	39.67	23.41	47.77	-	30.09	17.04
EV/Sales Ratio	10.20	5.40	11.92	11.59	8.01	5.76
EV/EBITDA Ratio	41.00	28.44	-	-	-	-
EV/EBIT Ratio	59.01	39.88	-	-	-	-
Debt / Equity Ratio	1.84	1.79	2.05	25.45	1.76	1.22
Debt / EBITDA Ratio	2.77	3.17	-	-	-	-
Net Debt / Equity Ratio	1.72	1.02	0.30	16.16	1.42	1.13
Net Debt / EBITDA Ratio	2.90	2.10	-1.47	-2.54	-4.67	-16.39
Net Debt / FCF Ratio	-2.55	-1.51	-0.57	-3.22	-2.94	-5.23
Asset Turnover	0.63	0.55	0.38	0.31	0.35	0.43
Inventory Turnover	2.96	2.45	2.17	1.88	1.78	2.11
Quick Ratio	0.61	0.58	0.62	0.34	0.51	0.59
Current Ratio	0.81	0.78	0.82	0.56	0.74	0.89
Return on Equity (ROE)	43.94%	31.02%	-129.89%	-211.59%	-41.52%	-45.49%
Return on Assets (ROA)	6.83%	4.67%	-4.33%	-7.78%	-4.32%	-1.95%
Return on Invested Capital (ROIC)	14.26%	18.13%	-29.84%	-37.48%	-16.44%	-7.46%
Return on Capital Employed (ROCE)	27.80%	19.00%	-17.90%	-54.00%	-19.30%	-7.90%
Earnings Yield	1.40%	1.43%	-2.70%	-5.83%	-2.73%	-3.86%
FCF Yield	-2.67%	-5.35%	-2.07%	-1.98%	-2.85%	-1.93%
Payout Ratio	28.83%	56.30%	-	-	-	-
Buyback Yield / Dilution	0.26%	0.01%	0.00%	1.92%	-1.13%	-0.83%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.